Natália Araújo was born in Langres, Champagne-Ardennes, France where she lived until she was 16 years old. She completed high school at Vila do Conde. She has a PharmD (six-year curriculum program, Faculty of Pharmacy, University of Porto, 2001). She was a fellow of the Institute of Molecular Biology for one year and a half (POCTI- PL 062203-BIC “Estudo de marcadores imunológicos no tratamento da leishmaniose com derivados poliamínicos e Doenças inflamatórias intestinais: doença de Crohn”), and she worked as a community pharmacist at Porto for ten years. In 2014, she decided to change her career, bringing together her interest in scientific investigation and the contact with people, and she enrolled in the Master in Public Health. In 2015, she completed the postgraduate course in Public Health (curricular year, Faculty of Medicine) and she got the Master degree in Pharmaceutical Sciences, with the public defense of the monography Pharmacogenomics: uses and potentialities. She was a research fellow of the project NEON-BC: A five-year prospective cohort study on the neurological complications of breast cancer: frequency and impact in patient-reported outcomes (POCI-01-0145-FEDER-016867) and she is currently a PhD student in Public Health (Faculty of Medicine, University of Porto) with a grant from the Foundation for Science and Technology (SFRH / BD / 119390/2016), for the thesis project Longitudinal assessment of cognitive decline in breast and prostate cancer survivors. She is a member of the Non Communicable Diseases Epidemiology research group (EPIUnit ISPUP).